Early caffeine therapy and clinical outcomes in extremely preterm infants

Prediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature Infants

(2011) Matthew M. Laughon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism

(2011) Jun Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Caffeine and brain development in very preterm infants

(2010) Lex W. Doyle et al.   ANNALS OF NEUROLOGY

Economic Evaluation of Caffeine for Apnea of Prematurity

(2010) D. Dukhovny et al.   PEDIATRICS

Patent Ductus Arteriosus of the Preterm Infant

(2010) S. E. G. Hamrick et al.   PEDIATRICS

Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network

(2010) B. J. Stoll et al.   PEDIATRICS

Caffeine for Apnea of Prematurity Trial: Benefits May Vary in Subgroups

(2009) Peter G. Davis et al.   JOURNAL OF PEDIATRICS

Prevention of bronchopulmonary dysplasia

(2009) Matthew M. Laughon et al.   Seminars in Fetal & Neonatal Medicine

Acute hemodynamic effects of caffeine administration in premature infants

(2008) V Soloveychik et al.   Journal of Perinatology

Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants

(2008) Barbara Schmidt et al.   Neonatology

Intensive Care for Extreme Prematurity — Moving beyond Gestational Age

(2008) Jon E. Tyson et al.   NEW ENGLAND JOURNAL OF MEDICINE